Working together to increase patient access to new, innovative medicines.
The Charity Medicines Access Coalition works to find long-term solutions to the challenges that can delay or prevent patient access to new and innovative medicines.
The coalition is co-chaired by Alzheimer’s Research UK and Cancer Research UK and brings together 10 health charities across disease areas. Coalition members jointly represent millions of patients and are major funders of research.
Working together, we strengthen charity voices in debates around new medicines. We make sure patients are at the heart of discussions about affordability and the value of new medicines.
The Charity Medicines Access Coalition believes new medicines:
- Offer life-saving and life-enhancing benefits for patients, their families and carers.
- Drive scientific research and innovation.
- Support research and development for future drug discovery.
- Support the UK economy.
To help support discussions around new medicines, the coalition has established relationships with decision-makers across the healthcare system. This includes the National Institute for Health and Care Excellence (NICE) and the Association of the British Pharmaceutical Industry (ABPI).